1. Home
  2. Labeler Index
  3. Teva Women's Health, Inc.
  4. NDC Product Code: 51285-138 Adenovirus Type 4 And Type 7 Vaccine, Live

NDC 51285-138 Adenovirus Type 4 And Type 7 Vaccine, Live

Kit - View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. Product Characteristics
  4. What is NDC 51285-138?
  5. Adenovirus Type 4 And Type 7 Vaccine, Live Uses
  6. Active Ingredients UNII Codes
  7. Inactive Ingredients UNII Codes
  8. NDC to RxNorm Crosswalk

Product Information

Get all the details for National Drug Code (NDC) 51285-138 in one place. This page breaks down everything you need to know about the NDC, including proprietary name, active and inactive substances, package configurations, billing units, labeler information, and routes of administration. It also includes enhanced data such as HCPCS codes, FDA product labels with images, UNIIs, and RxNorm cross-references. Whether you're a healthcare professional verifying drug data or a consumer researching medication, this NDC page helps you make informed, accurate decisions.

NDC Product Code:
51285-138
Proprietary Name:
Adenovirus Type 4 And Type 7 Vaccine, Live
Non-Proprietary Name: [1]
Adenovirus Type 4 And Type 7 Vaccine, Live
NDC Directory Status:
Vaccine
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Kit - A packaged collection of related material.
Labeler Name: [5]
Teva Women's Health, Inc.
Labeler Code:
51285
Product Label ID:
c7d0b43c-7250-4809-8a05-fcde5862f076
FDA Application Number: [6]
BLA125296
Marketing Category: [8]
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date: [9]
09-16-2011
Listing Expiration Date: [11]
12-31-2025
Exclude Flag: [12]
N
Code Navigator:

Product Characteristics

Color(s):
WHITE (C48325)
ORANGE (C48331 - LIGHT PEACH)
Shape:
ROUND (C48348)
Size(s):
10 MM
Imprint(s):
B4
B7
Score:
1

Code Structure Chart

Product Details

What is NDC 51285-138?

The NDC code 51285-138 is assigned by the FDA to the product Adenovirus Type 4 And Type 7 Vaccine, Live which is a vaccine label product labeled by Teva Women's Health, Inc.. The product's dosage form is kit. The product is distributed in a single package with assigned NDC code 51285-138-50 1 kit in 1 carton * 100 tablet, coated in 1 bottle (51285-175-02) * 100 tablet, coated in 1 bottle (51285-174-02). This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Adenovirus Type 4 And Type 7 Vaccine, Live?

Adenovirus Type 4 and Type 7 Vaccine, Live, Oral is a vaccine indicated for active immunization for the prevention of febrile acute respiratory disease caused by Adenovirus Type 4 and Type 7. Adenovirus Type 4 and Type 7 Vaccine, Live, Oral is approved for use in military populations 17 through 50 years of age.

Which are Adenovirus Type 4 And Type 7 Vaccine, Live UNII Codes?

The UNII codes for the active ingredients in this product are:

  • HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 (UNII: FKD3DUK39I)
  • HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 (UNII: FKD3DUK39I) (Active Moiety)
  • HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 (UNII: TM54L796SN)
  • HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 (UNII: TM54L796SN) (Active Moiety)

Which are Adenovirus Type 4 And Type 7 Vaccine, Live Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for Adenovirus Type 4 And Type 7 Vaccine, Live?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 1099936 - adenovirus type 4 vaccine, live 32,000 TCID50 Delayed Release Oral Tablet
  • RxCUI: 1099936 - adenovirus type 4 vaccine live 32000 UNT Delayed Release Oral Tablet
  • RxCUI: 1099940 - adenovirus type 7 vaccine, live 32,000 TCID50 Delayed Release Oral Tablet
  • RxCUI: 1099940 - adenovirus type 7 vaccine live 32000 UNT Delayed Release Oral Tablet
  • RxCUI: 1099941 - {100 (adenovirus type 4 vaccine live 32000 UNT Delayed Release Oral Tablet) / 100 (adenovirus type 7 vaccine live 32000 UNT Delayed Release Oral Tablet) } Pack

* Please review the disclaimer below.

Product Footnotes

[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".